PRIMAVERA: A Modular Phase I/II Study to Evaluate the Safety, Tolerability, and Efficacy of AZD3470, a Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor, in Participants with Relapsed/Refractory Hematologic MalignanciesTae Min Kim,Katharine L. Lewis,Juan Pablo Alderuccio,Hun Ju Lee,Enrico Derenzini,Pier Luigi Zinzani, Marco Ladetto,Herve Ghesquieres,Elizabeth H. Phillips,Francois Lemonnier,Franck Morschhauser, Ana Sureda Balari,Antonia Rodriguez Izquierdo,Peter Borchmann,Matthew Weinstock,Jakub Svoboda,Emma Dean,Jelena Urosevic,Stefanie Meyer,Robert Chen,Richard Olsson,Kaitlyn Beyfuss,Graham P. CollinsBLOOD（2024）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
